Complex Peptides

Reliable solid support systems backed by strong chemistry expertise and capabilities for complex molecule development.

Patient-focused sublingual dosage forms supporting convenient and effective drug delivery.

A broad range of syrup formulations developed to support diverse patient and therapeutic needs.

A comprehensive tablet portfolio spanning diverse therapeutic categories and patient needs.

A versatile portfolio of vial-based products supported by reliable manufacturing and quality standards.

API

Specialized capabilities in iron complexes, supported by strong chemistry expertise and a commitment to quality and reliable supply.

Strong organic synthesis capabilities enabling the development of diverse and complex pharmaceutical molecules with quality at every stage.

Established achiral chemistry capabilities supporting diverse pharmaceutical development and manufacturing requirements.

Ampoule-based injectable solutions supported by robust manufacturing capabilities and consistent quality.

Innovative drug delivery formats designed to support convenience, ease of use and patient-centric care.

Expertise in azido and nitroso impurity characterization, supporting comprehensive quality and analytical requirements for pharmaceutical development.

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 24 state-of-the-art manufacturing facilities (16 API and 8 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly.